Prescription medication used to treat alcoholism. Naltrexone is intended to block the craving for alcohol and the pleasure of getting high.
This drug blocks brain cell receptors for opioids, natural opium-like substances produced by the body which may be abnormally high in autism. In a series of studies on this drug, the self-injury and social withdrawal of autistic persons was reduced significantly (Walters, Barrett, Feinstein, Mercurio, & Hole, 1990). Some investigators have found children on naltrexone had better eye contact and social behaviour as well as less aggression and stereotypical behaviours. Also see opioid related theories.
an oral antagonist against the action of opiates
an opioid blocking drug so if you take opioids there should be no effect
A drug that was synthesized by Blumberg in 1965; it is a competitive agonist of the opiate receptors and progressively inhibits sensitivity to opiates. It was commercialized in 1987 when it was successively used for treating drug addiction relapses and as part of detoxification programs based on substitute and/or symptomatic drugs. It can cause violent withdrawal effects in persons addicted to narcotic drugs and therefore protocols using naltrexone must only be used 7-10 days after the drug addict has abstained from using opiates. It has proved to be a valid alternative in treatment based on agonists for patients that are motivated to stop using opiates and agonists on a daily basis. It is also reduces alcohol craving. Commercial names: Antaxone; Nalorex.
A long-lasting narcotic antagonist that blocks opiate receptors. Used to treat heroin addiction.
a drug used to treat opiate (e.g., heroin) addiction and alcoholism. Naltrexone blocks the opiate receptors, preventing cells from responding to opiate drugs and endorphins. Naltrexone has been used as an immune modulator by some people with HIV disease.
Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. Another in the family of opiod receptor competitive antagonists like Nalonxone, this blocking of opioid receptors is the basis behind its action in the management of opioid dependence-it reversibly blocks or attenuates the effects of opioids.
A long-lasting opiate antagonist used for the treatment of heroin addiction, and more recently used for the treatment of alcohol addiction.
A medication that may reduce the craving for alcohol and may lessen the alcoholic "high"; further study is still needed.
A drug that has been effective in the recovery from alcoholism. It blocks receptors for endorphins, thereby reducing alcohol cravings. Use of the drug in combination with psychosocial therapy improves the effectiveness of treatment.
An opiate antagonist used to treat heroin addiction, and more recently for the treatment of alcohol addiction.
Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and was formerly marketed using the trade name Revia. In some countries, an extended-release formulation is marketed under the trade name Vivitrol.